Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

NCT04444752 is registered in ClinicalTrials.gov with Connect Biopharm LLC as lead sponsor.

NCT NCT04444752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Multi-Centered Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
Lead sponsor
Connect Biopharm LLC
Phase
Phase 2
Overall status
Completed
Start date
July 17, 2020
Completion date
September 22, 2021
Enrollment
226 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

moderate-to-severe atopic dermatitis